Underutilization of statins in patients with type 2 diabetes in US clinical practice: A retrospective cohort study

Current Medical Research and Opinion

Volumn 27, Issue 5, 2011, Pages 1035-1040

  Fu, Alex Z ^a   Zhang, Qiaoyi ^b   Davies, Michael J ^b   Pentakota, Sri Ram ^b   Radican, Larry ^b   Seck, Thomas ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cardiovascular risk; Clinical inertia; Statins; type 2 diabetes

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DRUG USE; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; RETROSPECTIVE STUDY; SMOKING;

ADULT; AGE FACTORS; AGED; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 79954496607     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.567257     Document Type: Article

References (22)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics- 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215.
2. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34. (Pubitemid 28350165)
3. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44. (Pubitemid 23046633)
4. Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117-25.
5. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39. (Pubitemid 38924592)
6. Standards of medical care in diabetes-2011. Diabetes Care 2011;34(Suppl 1):S11-61.
7. Cheung BM, Ong KL, Cherny SS, et al. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med 2009;122:443-53.
8. Mann DM, Woodward M, Ye F, et al. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med 2009;169:1718-20.
9. van den HP, Heintjes E, Plat AW, et al. Determination of non-treatment with statins of high risk patients in The Netherlands. Curr Med Res Opin 2010;26:271-8.
10. Malik S, Lopez V, Chen R, et al. Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Res Clin Pract 2007;77:126-33. (Pubitemid 46590472)
11. Charpentier G, Genes N, Vaur L, et al. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab 2003;29:152-8. (Pubitemid 36576094)
12. Robinson JG, Booth B. Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006. J Clin Lipidol 2010;4:483-90.
13. Pyorala K, Lehto S, De Bacquer D, et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys. Diabetologia 2004;47:1257-65. (Pubitemid 39093321)
14. Standards of medical care in diabetes-2008. Diabetes Care 2008; 31(Suppl 1):S12-54.
15. Oderda G, Lieberman M, Asche C, et al. Use of electronic medical record (EMR) data in outcomes research. Value Health 2007;10:A450-1.
16. Steinberg BA, Braganza AJ, Eminowicz G, et al. Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18. Crit Pathw Cardiol 2005;4:169-73. (Pubitemid 41697496)
17. Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, et al. Statin adherence and the risk of major coronary events in patients with diabetes a nested case-control study. Br J Clin Pharmacol 2010; doi: 10.1111/j.1365- 2125. 2010.03895.x. [Epub ahead of print].
18. Donnelly LA, Doney AS, Morris AD, et al. Long-term adherence to statin treatment in diabetes. Diabet Med 2008;25:850-5.
19. AB E, Denig P, van Vliet T, Dekker JH. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Fam Pract 2009;10:24.
20. Tsang JL, Mendelsohn A, Tan MK, et al. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy. Am J Cardiol 2008;102:1142-5.
21. Mills EJ, Wu P, Chong G, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials. QJM 2010;104:109-24.
22. Lardizabal JA, Deedwania PC. Benefits of statin therapy and compliance in high risk cardiovascular patients. Vasc Health Risk Manag 2010;6:843-53